This inventor holds 9 USPTO granted patents, plus 2 CIPO patents and 3 EPO patents. Top assignees: Eisai R&d Management Co., Ltd., Allelix-Pharm-Eco L.p.. Active years: 1998-2015.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1998-2015
Title: Kuo-Ming Wu: Innovator in Immunological Adjuvants
Introduction
Kuo-Ming Wu is a prominent inventor based in Acton, MA (US). He has made significant contributions to the field of immunology, particularly in the development of adjuvants that enhance the efficacy of vaccines. With a total of 9 patents to his name, Wu's work has had a substantial impact on medical research and pharmaceutical development.
Latest Patents
One of Wu's latest patents is focused on "Compounds for preparing immunological adjuvant." This invention provides methods for preparing TLR-4 receptor agonist E6020, which is crucial for improving immune responses. His innovative approaches in this area are paving the way for more effective immunological treatments.
Career Highlights
Throughout his career, Kuo-Ming Wu has worked with notable companies such as Eisai R&D Management Co., Ltd. and Allelix Pharm-Eco L.P. His experience in these organizations has allowed him to collaborate with leading experts in the field and contribute to groundbreaking research.
Collaborations
Wu has collaborated with esteemed colleagues, including Francis Gerard Fang and James E. Foy. These partnerships have further enriched his research and innovation efforts, leading to advancements in immunological therapies.
Conclusion
Kuo-Ming Wu's contributions to the field of immunology through his patents and collaborations highlight his role as a key innovator. His work continues to influence the development of effective immunological adjuvants, showcasing the importance of innovation in healthcare.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
